Observational Registry Study for Chronic Plaque Psoriasis

Adults aged 18 years or older with a diagnosis of chronic plaque psoriasis may qualify to participate. Individuals must have moderate to severe disease according to physician’s clinical judgment. Both biologic naïve psoriasis patients (i.e. not previously treated with a biologic drug) and biologic experienced psoriasis patients (i.e. previously treated with a biologic drug) may be eligible.

This is an observational registry study that will enroll patients who are initiating an approved biological therapy for the management of moderate to severe chronic plaque psoriasis, in normal clinical practice.

Study observation is about 3 years (37 months) and involves up to 14 visits to the study centre, as part of routine standard of care visits.

Call the study centre near you, or register now.

Learn more about
Register Now!

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more